All Type of News
What if a drug for both ‘premature ejaculation’ and ‘impotence’ at the same time… Doctors are also interested
‘Premature ejaculation’ and ‘impotence’ are commonly known as major sexual dysfunction disease among middle-aged men. It was a popular idea among urologists that it would be interesting if a drug, which can cure both ...
The National Assembly was focused on examination in regards to social contribution and clinical trials of multinational pharmaceutical companies
Health and Welfare Committee of the National Assembly conducted witness examination at the national inspection on this 20th to check if multinational pharmaceutical companies have contributed enough to the Korean soci...
The future of new natural product drugs, facing critical situationDespite the government’s development policy of new natural product drugs, negative market recognition towards new natural product drugs has continuously spread. Natural product ...
|
.jpg)
“The recruitment for Ebola doctors and nurses will begin this week”
On the beginning of the coming November, the Korean medical manpower is expected to be dispatched in Ebola-stricken areas. The government planned to recruit dispatched medical manpower, such as infectious disease spec...
Despite the decline of its prescription, Baraclude still stays in the top… Viread is chasing aggresively
The hepatitis B drug, ‘Viread’ emerging as a star from a dark horse, has been accelerated to catch ‘Baraclude’.
According to the Medipana News’s accumulated results created based on the UBIST’s
data of collective pre...
RB Korea became an official member of KRPIA recently
RB Korea’s effort to establish image as a pharmaceutical company is actively ongoing.
According to a person concerned on the 21st, RB Korea recently finished to register as a official member of Korean Research-based ...
Pharmaceutical distribution companies aiming right at the abnormal distribution cost of Pfizer
The pharmaceutical distribution industry has got in preparation to straighten up abnormal distribution cost of Pfizer Korea.
Even though the break-even points of most pharmaceutical distribution companies are late-8%...
Domestic pharmaceutical companies’ changes in means of overseas expansion to reduce risks
There have been changes in means of domestic pharmaceutical companies’ overseas expansion in Korea. They used to be direct infiltration strategies in the past, but now they are moving towards indirect infiltration str...
The next year’s budget cuts for new drug development projects led by the government
The next year’s budget for new drug development projects led the government will be decreased by 10%. After the three years of implementation, the global pharmaceutical industry promotion fund got combined with the sm...
“Are citizens lab rats? We’ll fight until the end.”
In order to resist on the telemedicine system, doctors from all over the country gathered up.
Korea Doctors Association (president Joong-il Kim/hereinafter referring to KDA) held the starting ceremony of ‘Emergency P...
